BIOMAT Database Logo BIOMAT Database Logo

[CLINICAL EXPERIENCES WITH A NEW SECRETOLYTIC (BISOLVON) BY USING SUBJECTIVE AND OBJECTIVE METHODS]. 1964

P GOEBEL, and E GOEBEL-RIEKEN

UI MeSH Term Description Entries
D001964 Bromhexine A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744) Aparsonin,Bisolvon,Bromhexin,Bromhexin BC,Bromhexin Berlin-Chemie,Bromhexin-ratiopharm,Bromhexine Hydrochloride,Bromhexine Monohydrochloride,Brotussol,Darolan,Dur-Elix,Famel Bromhexine,Flegamin,Flubron,Hustentabs-ratiopharm,Mucohexine,NA-274,Quentan,Tesacof,bromhexin von ct,BC, Bromhexin,Bromhexin Berlin Chemie,Bromhexin BerlinChemie,Bromhexin ratiopharm,Bromhexine, Famel,Bromhexinratiopharm,Dur Elix,DurElix,Hustentabs ratiopharm,Hustentabsratiopharm,Hydrochloride, Bromhexine,Monohydrochloride, Bromhexine,NA 274,NA274,ct, bromhexin von,von ct, bromhexin
D001987 Bronchiectasis Persistent abnormal dilatation of the bronchi. Cylindrical Bronchiectasis,Cystic Bronchiectasis,Saccular Bronchiectasis,Varicose Bronchiectasis,Bronchiectases,Bronchiectasis, Cylindrical,Bronchiectasis, Cystic,Bronchiectasis, Saccular,Bronchiectasis, Varicose,Cylindrical Bronchiectases,Cystic Bronchiectases,Saccular Bronchiectases,Varicose Bronchiectases
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D004358 Drug Therapy The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER. Chemotherapy,Pharmacotherapy,Therapy, Drug,Chemotherapies,Drug Therapies,Pharmacotherapies,Therapies, Drug
D005100 Expectorants Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. Expectorant,Mucolytic,Mucolytic Agent,Mucolytic Agents,Mucolytics,Agent, Mucolytic,Agents, Mucolytic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises
D035843 Biomedical Research Research that involves the application of the natural sciences, especially biology and physiology, to medicine. Medical Research,Experimental Medicine,Investigational Medicine,Investigative Medicine,Research, Biomedical,Research, Medical,Medicine, Experimental,Medicine, Investigational,Medicine, Investigative

Related Publications

P GOEBEL, and E GOEBEL-RIEKEN
[Experiences with the new secretolytic Bisolvon].
December 1965, Medizinische Klinik,
P GOEBEL, and E GOEBEL-RIEKEN
"Objective" methods and "subjective" experiences.
January 1989, Schizophrenia bulletin,
P GOEBEL, and E GOEBEL-RIEKEN
[Biochemical, pharmacological and clinical observations in connection with the broncho-secretolytic, bisolvon].
June 1970, Medizinische Monatsschrift,
P GOEBEL, and E GOEBEL-RIEKEN
[In-vitro studies with the secretolytic agent Bisolvon (supplement to preliminary clinico-experimental experiences)].
November 1965, Praxis,
P GOEBEL, and E GOEBEL-RIEKEN
[Clinical experience with a new secretolytic drug].
September 1969, Minerva medica,
P GOEBEL, and E GOEBEL-RIEKEN
[Clinical experiences in parenteral treatment with a broncho-secretolytic agent].
July 1966, Medizinische Monatsschrift,
P GOEBEL, and E GOEBEL-RIEKEN
[Secretolytic bisolvon in the treatment of chronic bronchitis and bronchial asthma].
January 1968, Lijecnicki vjesnik,
P GOEBEL, and E GOEBEL-RIEKEN
[Clinical trial of a new substance with secretolytic action].
September 1969, Minerva medica,
P GOEBEL, and E GOEBEL-RIEKEN
[Our clinical experience with a new antitussive secretolytic drug].
September 1969, Minerva medica,
P GOEBEL, and E GOEBEL-RIEKEN
[A NEW SECRETOLYTIC AGENT FROM A CLINICAL VIEWPOINT].
April 1965, Die Medizinische Welt,
Copied contents to your clipboard!